Alnylam announces planned transition of barry greene, president

Alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that after 17 years, barry greene, president, has
ALNY Ratings Summary
ALNY Quant Ranking